More about

Hepatocellular Carcinoma

News
February 26, 2021
3 min read
Save

Q&A: Longest survival among HCC patients seen with ‘breakthrough’ drug combination

In an exclusive interview with Healio Gastroenterology, Richard Finn, MD, discussed the results from a recent study of patients with hepatocellular carcinoma treated with combination therapy comprising atezolizumab, an immunotherapy drug and monoclonal antibody, and bevacizumab, another monoclonal antibody against the vascular endothelial growth factor (VEGF).

News
February 25, 2021
4 min read
Save

Current liver cancer screening protocols may miss at-risk Black individuals with HCV

Current liver cancer screening protocols may miss at-risk Black individuals with HCV

Despite having better liver function at diagnosis, Black patients with hepatitis C virus tended to have more aggressive hepatocellular carcinoma tumors compared with other racial groups, according to a study published in Cancer.

News
February 17, 2021
2 min read
Save

Incidence of liver cancer increases significantly among people with HIV

Incidence of liver cancer increases significantly among people with HIV

Hepatocellular carcinoma rates among people with HIV increased significantly from 1996 to 2015, according to a study published in JAMA Network Open.

News
January 19, 2021
4 min read
Save

Pembrolizumab shows promising OS for previously untreated advanced HCC

Pembrolizumab shows promising OS for previously untreated advanced HCC

First-line pembrolizumab induced durable antitumor activity and promising OS among patients with advanced hepatocellular carcinoma, according to data from the phase 2 KEYNOTE-224 study presented at Gastrointestinal Cancers Symposium.

News
January 19, 2021
4 min read
Save

Atezolizumab-bevacizumab combination provides ‘longest survival seen’ in advanced HCC

Atezolizumab-bevacizumab combination provides ‘longest survival seen’ in advanced HCC

Atezolizumab plus bevacizumab conferred the longest OS seen in a phase 3 study for treatment-naive advanced hepatocellular carcinoma, according to updated results of the IMbrave150 study presented at Gastrointestinal Cancers Symposium.

News
January 15, 2021
1 min read
Save

Validated risk score predicts post-transplant survival in HCC

Investigators developed a validated risk score to predict post-transplant survival for patients with hepatocellular carcinoma that will help prioritize patients based on predicted survival, according to study results.

News
January 13, 2021
1 min read
Save

Endoscopic biliary drainage leads to high technical success rate in HCC

Clinicians may be able to safely perform endoscopic biliary drainage for patients with hepatocellular carcinoma with jaundice and liver dysfunction with a high technical success rate, according to a study in BMC Gastroenterology.

News
January 08, 2021
3 min read
Save

7 recent reports in hepatology

Healio Gastroenterology presents the following reports on the most recent research in hepatology.

News
January 07, 2021
1 min read
Save

Alcohol-related liver disease increases risk for cancer

Patients with alcohol-related liver disease who survive for at least 1 year after diagnosis are at increased risk for cancer, according to study results.

News
December 30, 2020
1 min read
Save

Black patients with HCC have worse overall survival

Black patients with hepatocellular carcinoma have worse overall survival compared with white patients, according to study results.

View more